Daniel B. Silvers - Jun 30, 2021 Form 4 Insider Report for Ensysce Biosciences, Inc. (ENSC)

Role
10%+ Owner
Signature
/s/ Daniel Silvers
Stock symbol
ENSC
Transactions as of
Jun 30, 2021
Transactions value $
$2,004,497
Form type
4
Date filed
7/1/2021, 07:50 PM
Previous filing
Jun 11, 2021
Next filing
Jan 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENSC Warrants Award $1.64M +1.64M $1.00 1.64M Jun 30, 2021 Common Stock 1.64M $11.50 MLCP GLL Funding LLC F1, F2
transaction ENSC Warrants Award $367K +367K +22.42% $1.00 2M Jun 30, 2021 Common Stock 367K $11.50 MLCP GLL Funding LLC F2, F3
transaction ENSC Warrants Disposed to Issuer $0 -250K -12.47% $0.00 1.75M Jun 30, 2021 Common Stock 250K $11.50 MLCP GLL Funding LLC F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects warrants of Ensysce Biosciences, Inc., formerly known as Leisure Acquisition Corp. (the "Issuer"), which were acquired from the Issuer at a price of $1.00 per warrant in a private placement that closed simultaneously with the closing of the Issuer's initial public offering which were later exchanged for warrants having the same terms, except that they are non-transferable other than to permitted transferees. Pursuant to the terms of the issuance, such warrants were not eligible to become exercisable unless the Issuer consummated its initial business combination which occurred on June 30, 2021. Mr. Silvers served as the Issuer's Chief Executive Officer and Director until the closing of the business combination.
F2 Matthews Lane Capital Partners LLC, a sponsor of the Issuer, is the manager of MLCP GLL Funding LLC, the record holder of the warrants. Mr. Silvers is the managing member of Matthews Lane Capital Partners LLC and disclaims beneficial ownership with respect to the securities except to the extent of his pecuniary interest therein.
F3 Reflects warrants acquired at a price of $1.00 per warrant upon the conversion of promissory notes of the Issuer reflecting amounts loaned to the Issuer pursuant to the Issuer's expense advancement agreement, which were convertible into warrants at the holder's option. The warrants are on the same terms as the warrants described in note (1) above.
F4 Reflects warrants surrendered to the Issuer in connection with the Issuer's business combination pursuant to a warrant surrender agreement, for no consideration.